4-nitrobenzofurazan has been researched along with sphingosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumruker, T; Billich, A; Ettmayer, P; Guerini, D; Mechtcheriakova, D; Nussbaumer, P; Streiff, MB | 1 |
1 other study(ies) available for 4-nitrobenzofurazan and sphingosine
Article | Year |
---|---|
NBD-labeled derivatives of the immunomodulatory drug FTY720 as tools for metabolism and mode of action studies.
Topics: Calcium; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Fingolimod Hydrochloride; Flow Cytometry; Humans; Immunosuppressive Agents; Lysophospholipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Oxadiazoles; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Protein Binding; Receptors, Lysosphingolipid; Recombinant Proteins; Sphingosine; Substrate Specificity; Time Factors | 2006 |